Patient Guide: A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 76 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05609370
Status: ACTIVE_NOT_RECRUITING
Condition: Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 76 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Anchorage, Alaska
  • Gilbert, Arizona
  • Cerritos, California
  • • And 73 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily